These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 38831379)

  • 1. YY1 mediated DCUN1D5 transcriptional activation promotes triple-negative breast cancer progression by targeting FN1/PI3K/AKT pathway.
    Lin Y; Li Y; Chen X; Jin X; Jiang M; Xiao H; Chen L; Chen M; Zhang W; Chen H; Nie Q; Guo R; Guo W; Fu F; Wang C
    Biol Direct; 2024 Jun; 19(1):42. PubMed ID: 38831379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calycosin inhibits triple-negative breast cancer progression through down-regulation of the novel estrogen receptor-α splice variant ER-α30-mediated PI3K/AKT signaling pathway.
    Li Y; Hu S; Chen Y; Zhang X; Gao H; Tian J; Chen J
    Phytomedicine; 2023 Sep; 118():154924. PubMed ID: 37393829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-5590-3p-YY1 feedback loop promotes the proliferation and migration of triple-negative breast cancer cells.
    Liang F; Fu X; Wang L
    J Cell Biochem; 2019 Oct; 120(10):18415-18424. PubMed ID: 31190375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WBP2 Downregulation Inhibits Proliferation by Blocking YAP Transcription and the EGFR/PI3K/Akt Signaling Pathway in Triple Negative Breast Cancer.
    Song H; Wu T; Xie D; Li D; Hua K; Hu J; Fang L
    Cell Physiol Biochem; 2018; 48(5):1968-1982. PubMed ID: 30092563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. YY1 regulates the proliferation and invasion of triple-negative breast cancer via activating PLAUR.
    Zhang C; Chen S; Wang W; Gao Y
    Funct Integr Genomics; 2023 Aug; 23(3):269. PubMed ID: 37552345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PRR15 deficiency facilitates malignant progression by mediating PI3K/Akt signaling and predicts clinical prognosis in triple-negative rather than non-triple-negative breast cancer.
    Guo F; Ma J; Li C; Liu S; Wu W; Li C; Wang J; Wang J; Li Z; Zhai J; Sun F; Zhou Y; Guo C; Qian H; Xu B
    Cell Death Dis; 2023 Apr; 14(4):272. PubMed ID: 37072408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of microRNA variants on PI3K/AKT signaling in triple-negative breast cancer: comprehensive review.
    Mehrtabar E; Khalaji A; Pandeh M; Farhoudian A; Shafiee N; Shafiee A; Ojaghlou F; Mahdavi P; Soleymani-Goloujeh M
    Med Oncol; 2024 Aug; 41(9):222. PubMed ID: 39120634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type X collagen knockdown inactivate ITGB1/PI3K/AKT to suppress chronic unpredictable mild stress-stimulated triple-negative breast cancer progression.
    Liu J; Chai XX; Qiu XR; Sun WJ; Tian YL; Guo WH; Yin DC; Zhang CY
    Int J Biol Macromol; 2024 Jul; 273(Pt 1):133074. PubMed ID: 38866293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SPAG5 upregulation contributes to enhanced c-MYC transcriptional activity via interaction with c-MYC binding protein in triple-negative breast cancer.
    Li M; Li A; Zhou S; Lv H; Yang W
    J Hematol Oncol; 2019 Feb; 12(1):14. PubMed ID: 30736840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Micropeptide CIP2A-BP encoded by LINC00665 inhibits triple-negative breast cancer progression.
    Guo B; Wu S; Zhu X; Zhang L; Deng J; Li F; Wang Y; Zhang S; Wu R; Lu J; Zhou Y
    EMBO J; 2020 Jan; 39(1):e102190. PubMed ID: 31755573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone deacetylase inhibitors suppress mutant p53 transcription via HDAC8/YY1 signals in triple negative breast cancer cells.
    Wang ZT; Chen ZJ; Jiang GM; Wu YM; Liu T; Yi YM; Zeng J; Du J; Wang HS
    Cell Signal; 2016 May; 28(5):506-515. PubMed ID: 26876786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CircTRIM1 encodes TRIM1-269aa to promote chemoresistance and metastasis of TNBC via enhancing CaM-dependent MARCKS translocation and PI3K/AKT/mTOR activation.
    Li Y; Wang Z; Yang J; Sun Y; He Y; Wang Y; Chen X; Liang Y; Zhang N; Wang X; Zhao W; Hu G; Yang Q
    Mol Cancer; 2024 May; 23(1):102. PubMed ID: 38755678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ROR2 promotes invasion and chemoresistance of triple-negative breast cancer cells by activating PI3K/AKT/mTOR signaling.
    DA X; Ge H; Shi J; Zhu C; Wang G; Fang Y; Xu J
    Oncol Res; 2024; 32(7):1209-1219. PubMed ID: 38948021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of GPER suppresses epithelial mesenchymal transition of triple negative breast cancer cells via NF-κB signals.
    Chen ZJ; Wei W; Jiang GM; Liu H; Wei WD; Yang X; Wu YM; Liu H; Wong CK; Du J; Wang HS
    Mol Oncol; 2016 Jun; 10(6):775-88. PubMed ID: 26842883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SETD7 promotes metastasis of triple-negative breast cancer by YY1 lysine methylation.
    Gao L; Zhang J; Long Q; Yang Y; Li Y; Li G; Pu P; Tong S; He Y; Li Q; Chen Y; Liu Y; Kong X
    Biochim Biophys Acta Mol Basis Dis; 2023 Oct; 1869(7):166780. PubMed ID: 37286143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. YY1-mediated long non-coding RNA Kcnq1ot1 promotes the tumor progression by regulating PTEN via DNMT1 in triple negative breast cancer.
    Shen B; Li Y; Ye Q; Qin Y
    Cancer Gene Ther; 2021 Nov; 28(10-11):1099-1112. PubMed ID: 33323961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Higher levels of TIMP-1 expression are associated with a poor prognosis in triple-negative breast cancer.
    Cheng G; Fan X; Hao M; Wang J; Zhou X; Sun X
    Mol Cancer; 2016 Apr; 15(1):30. PubMed ID: 27130446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MAPK4 promotes triple negative breast cancer growth and reduces tumor sensitivity to PI3K blockade.
    Wang W; Han D; Cai Q; Shen T; Dong B; Lewis MT; Wang R; Meng Y; Zhou W; Yi P; Creighton CJ; Moore DD; Yang F
    Nat Commun; 2022 Jan; 13(1):245. PubMed ID: 35017531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CircWAC induces chemotherapeutic resistance in triple-negative breast cancer by targeting miR-142, upregulating WWP1 and activating the PI3K/AKT pathway.
    Wang L; Zhou Y; Jiang L; Lu L; Dai T; Li A; Chen Y; Zhang L
    Mol Cancer; 2021 Mar; 20(1):43. PubMed ID: 33648498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MEX3A promotes triple negative breast cancer proliferation and migration via the PI3K/AKT signaling pathway.
    Jiang S; Meng L; Chen X; Liu H; Zhang J; Chen F; Zheng J; Liu H; Wang F; Hu J; Li Z
    Exp Cell Res; 2020 Oct; 395(2):112191. PubMed ID: 32738346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.